Literature DB >> 23160823

Visual function after pars plana vitrectomy in macular edema with branch retinal vein occlusion.

Hidetaka Noma1, Katsunori Shimada, Tatsuya Mimura.   

Abstract

The objective of this study is to evaluate functional and morphological changes of the macula after pars plana vitrectomy (PPV) for macular edema with branch retinal vein occlusion (BRVO). Eighteen patients with BRVO (mean age: 71.3 ± 5.9 years; six women and 12 men) received PPV. Macular function was documented by microperimetry and best-corrected visual acuity (BCVA) was determined. Retinal thickness and retinal volume were measured by optical coherence tomography (OCT), and mean retinal sensitivity was calculated for each of nine macular subfields. Ischemia and serous retinal detachment (SRD) were evaluated by fluorescein angiography and OCT, respectively. Mean BCVA was significantly improved at 3 and 6 months after PPV. Mean retinal sensitivity, retinal thickness, and retinal volume were significantly improved after 3 and 6 months in five, eight, and eight subfields, respectively. Improvement of visual acuity and the percent change in retinal thickness or retinal volume were not correlated in any of the nine subfields, while improvement of retinal sensitivity was correlated with the percent change in both retinal thickness and retinal volume in the temporal outer subfield. There were significant differences with respect to the percent changes in retinal thickness and volume in the temporal outer field between the non-ischemic and ischemic groups, as well as between the patients with and without SRD. There was also a significant difference between the non-ischemic and ischemic groups with respect to the improvement of retinal sensitivity in three out of nine fields. These findings suggest that PPV can improve both functional and morphological changes due to macular edema in BRVO patients, and that morphological improvement in the temporal outer subfield after PPV might influence the functional prognosis of these patients.

Entities:  

Mesh:

Year:  2012        PMID: 23160823     DOI: 10.1007/s10792-012-9676-4

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  25 in total

1.  Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.

Authors:  Ingrid U Scott; Paul C VanVeldhuisen; Neal L Oden; Michael S Ip; Barbara A Blodi; Mary Elizabeth Hartnett; Geoff Cohen
Journal:  Ophthalmology       Date:  2011-02       Impact factor: 12.079

2.  Initial visual acuity is an important prognostic factor in patients with branch retinal vein occlusion.

Authors:  Jiri Rehak; Ladislav Dusek; Oldrich Chrapek; Evzen Fric; Matus Rehak
Journal:  Ophthalmic Res       Date:  2010-11-16       Impact factor: 2.892

3.  Functional-morphological changes after intravitreal injection of triamcinolone acetonide for macular edema with branch retinal vein occlusion.

Authors:  Hidetaka Noma; Hideharu Funatsu; Tatsuya Mimura; Katsunori Shimada
Journal:  J Ocul Pharmacol Ther       Date:  2012-02-03       Impact factor: 2.671

4.  Retinal sensitivity after intravitreal injection of bevacizumab for the treatment of macular edema secondary to retinal vein occlusion.

Authors:  Noritatsu Yamaike; Akitaka Tsujikawa; Atsushi Sakamoto; Masafumi Ota; Yuriko Kotera; Kazuaki Miyamoto; Mihori Kita; Nagahisa Yoshimura
Journal:  Retina       Date:  2009-06       Impact factor: 4.256

5.  Functional-morphologic correlates in patients with branch retinal vein occlusion and macular edema.

Authors:  Hidetaka Noma; Hideharu Funatsu; Tatsuya Mimura; Seiyo Harino; Katsunori Shimada
Journal:  Retina       Date:  2011-11       Impact factor: 4.256

6.  Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion.

Authors:  H Noma; H Funatsu; M Yamasaki; H Tsukamoto; T Mimura; T Sone; T Hirayama; H Tamura; H Yamashita; A Minamoto; H K Mishima
Journal:  Eye (Lond)       Date:  2006-07-07       Impact factor: 3.775

7.  The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology.

Authors:  E Stefánsson
Journal:  Acta Ophthalmol Scand       Date:  2001-10

8.  Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study.

Authors:  K Kriechbaum; S Michels; F Prager; M Georgopoulos; M Funk; W Geitzenauer; U Schmidt-Erfurth
Journal:  Br J Ophthalmol       Date:  2008-01-22       Impact factor: 4.638

9.  Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Branch Vein Occlusion Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1986-01

10.  Hypertension and hyperlipidemia management in patients treated at community health centers.

Authors:  Anne C Kirchhoff; Melinda L Drum; James X Zhang; Jennifer Schlichting; Jessica Levie; James F Harrison; Susan A Lippold; Cynthia T Schaefer; Marshall H Chin
Journal:  J Clin Outcomes Manag       Date:  2008
View more
  4 in total

1.  Effect of aflibercept in patients with age-related macular degeneration.

Authors:  Hiroko Okuma; Tatsuya Mimura; Mari Goto; Yuko Kamei; Maiko Yoshida; Aki Kondo; Masao Matsubara
Journal:  Int Ophthalmol       Date:  2015-06-05       Impact factor: 2.031

2.  Update in the Management of Macular Edema Following Retinal Vein Occlusions.

Authors:  Mariana R Thorell; Raquel Goldhardt
Journal:  Curr Ophthalmol Rep       Date:  2016-03-10

3.  Outcomes of microincision vitrectomy surgery with internal limiting membrane peeling for macular edema secondary to branch retinal vein occlusion.

Authors:  Shimpei Sato; Maiko Inoue; Shin Yamane; Akira Arakawa; Mikiro Mori; Kazuaki Kadonosono
Journal:  Clin Ophthalmol       Date:  2015-03-04

4.  Vitrectomy for macular edema due to retinal vein occlusion.

Authors:  Kazuyuki Kumagai; Nobuchika Ogino; Marie Fukami; Mariko Furukawa
Journal:  Clin Ophthalmol       Date:  2019-06-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.